---

---

tags : Pharmaceutical    crawled time : 08:00   

save search

---

Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -14.36% | O: -15.73% H: 0.0% C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K |

Health Technology

| -4.47% | O: -2.85% H: 12.13% C: 3.77%
pharma

---

Orexo announces changes in the company´s Board of Directors - October 27, 2023
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M |

Health Technology

| 30.81% | O: -1.5% H: 0.78% C: -0.29%

---

New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
CALT | News | $18.3 -2.35% -2.4% 6.1K |

Health Technology

| 8.55% | O: 2.58% H: 0.08% C: -3.42%
nefecon nephropathy drug approval treatment application

---

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - October 19, 2023
Published: 2023-10-19 (Crawled : 08:00) - biospace.com/
RARE F | $43.38 -1.65% -1.68% 770K |

Health Technology

| 39.02% | O: 3.81% H: 5.46% C: 1.55%
offering

---

Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder
Published: 2023-10-17 (Crawled : 08:00) - biospace.com/
TEVA | $12.78 -3.03% -0.24% 9M |

Health Technology

| 50.8% | O: -0.69% H: 1.27% C: -0.23%
ajovy depression teva migraine study

---

AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer (CDO) Dr. Mathieu Peeters and Chief Financial Officer (CFO) Barbara Freitag
Published: 2023-10-10 (Crawled : 08:00) - biospace.com/
BNPQY | $34.25 -2.68% 180K |

Finance and Insurance

| 8.57% | O: 1.02% H: 0.38% C: -0.44%
financial

---

Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
Published: 2023-10-06 (Crawled : 08:00) - biospace.com/
NAVB | $0.042 50.69% 12K |

Health Technology

| -48.65% | O: -54.94% H: 56.7% C: 39.32%

---

Innate Pharma Reports First Half 2023 Financial Results and Business Update
Published: 2023-09-14 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -13.74% | O: 2.14% H: 0.0% C: -1.3%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -16.08% | O: 0.26% H: 0.74% C: 0.33%
IPHA | $2.4 -0.42% -0.42% 11K |

Health Technology

| -23.2% | O: -5.23% H: 6.9% C: 5.74%
pharma business update financial results

---

Gilead Prices $2 Billion of Senior Unsecured Notes
Published: 2023-09-08 (Crawled : 08:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M |

Health Technology

| -9.52% | O: 2.95% H: 0.62% C: -0.16%

---

Reata Pharmaceuticals Announces Approval of Prior Approval Supplement for SKYCLARYS® (Omaveloxolone) and Commercial Availability of SKYCLARYS for Patients with Friedreich’s Ataxia
Published: 2023-06-28 (Crawled : 08:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0 |

Health Technology

| 86.56% | O: 6.1% H: 5.34% C: 0.82%
skyclarys approval pharmaceuticals commercial

---

Pfizer Prices $31,000,000,000 Debt Offering
Published: 2023-05-17 (Crawled : 08:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M |

Health Technology

| -31.32% | O: -0.08% H: 0.19% C: -0.62%
SGEN | $228.74 0.1% 20M |

Health Technology

| 21.9% | O: 1.85% H: 1.92% C: 1.01%
offering

---

LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
Published: 2023-03-10 (Crawled : 08:00) - biospace.com/
ICLR | $291.74 -0.1% -0.1% 500K |

Health Technology

| 31.78% | O: 0.83% H: 0.0% C: -4.27%
partnership leo pharma propel medical trial

---

Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
Published: 2022-12-13 (Crawled : 08:00) - biospace.com/
GLPG | $28.9 -1.1% -1.11% 140K |

Health Technology

| -23.93% | O: 2.21% H: 0.64% C: -0.25%
glpg5101 candidate car-t cd19

---

G1 Therapeutics Announces Pricing of Offering of Common Stock - November 18, 2022
Published: 2022-11-18 (Crawled : 08:00) - biospace.com/
GTHX | $4.16 -2.8% -2.88% 690K |

Health Technology

| -51.23% | O: -23.86% H: 2.92% C: -0.61%
offering therapeutics

---

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock - November 18, 2022
Published: 2022-11-18 (Crawled : 08:00) - biospace.com/
RAPT | $7.94 -1.24% -1.26% 710K |

Health Technology

| -62.27% | O: -7.32% H: 1.16% C: -7.7%
offering therapeutics

---

CANbridge Announces Encouraging Development in Maralixibat/LIVMARLI in Rare Liver Disease
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
MIRM | $23.6 -1.05% -1.06% 400K |

Health Technology

| 2.12% | O: 0.48% H: 2.41% C: -7.81%
rare liver disease

---

GSK, MorphoSys' Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
MOR | $18.02 -0.11% -0.11% 590K |

Health Technology

| 263.18% | O: -3.82% H: 6.9% C: 6.49%
program update

---

Ipsen Delivers Strong Sales Growth in the First Nine Months of 2022 and Confirms Its Full-year Guidance
Published: 2022-10-27 (Crawled : 08:00) - biospace.com/
EPZM | $1.47 -1.34% 0.0% |

Health Technology

| Email alert Add to watchlist
sales growth

---

Evotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT World
Published: 2022-10-18 (Crawled : 08:00) - biospace.com/
EVO | News | $7.19 -0.69% -0.7% 27K |

Manufacturing

| -18.81% | O: 4.45% H: 0.66% C: -0.55%
platform

---

Amylyx Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - October 07, 2022
Published: 2022-10-07 (Crawled : 08:00) - biospace.com/
AMLX | $1.97 -1.5% -1.52% 1M |

| -93.97% | O: -0.34% H: 3.55% C: -0.76%
offering pharmaceuticals

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---